EQL takes back Potassium Chloride rights in Denmark and Norway
On November 24, 2017, EQL announced that a license agreement has been entered into with a leading generic company for the license of EQL's product Potassium Chloride in Denmark, Norway and Finland. The agreement ran for three years and the reason for the out-licensing of Potassium Chloride was primarily that EQL at that time was not willing to tie up as much capital in stock as a launch of Potassium Chloride in these markets required. The license agreement was structured so that EQL received part of the profit from the sales of the product.When the agreement expired earlier this year, EQL